Interview with Sebastien Burel, PhD
Sebastien Burel, PhD Ionis Pharmaceuticals Director Nonclinical Development How did you become interested in the field of oligonucleotides? Mostly by accident.
Interview with Professor J George Dickson
Professor J George Dickson Chair of Molecular Cell Biology, School of Biological Sciences Royal Holloway - University of London, Egham, Surrey, TW20 0EX, UK.
Interview with Catherine McKeen, PhD
Catherine McKeen, PhD Operations Director Link Technologies How did you become interested in the field of oligonucleotides? I have worked in the oligonucleotide sector since 1994. Initially I worked with Tom Brown in
Interview with Jean Gariepy, PhD
Jean Gariepy, Ph.D. Professor Departments of Medical Biophysics and Pharmaceutical Sciences University of Toronto SRI Research Chair in Biomolecular Engineering and Senior Scientist Physical Sciences Sunnybrook Research Institute
Interview with Simon C. W. Richardson, BSc (Hons) MSc PhD FRSB CBiol
SIMON C. W. RICHARDSON BSc (Hons) MSc PhD FRSB CBiol. Director at Intracellular Delivery Solutions Ltd., and Senior Lecturer in Biopharmaceutics, University of Greenwich, UK. How did you become interested in the field of
Interview with Maire Fiona Osborn, PhD
Maire Fiona Osborn, Ph.D. Postdoctoral Associate, RNA Therapeutics Institute University of Massachusetts Medical School How did you become interested in the field of oligonucleotides? I took a somewhat circuitous route to the field of
Interview with Xianbin Yang, PhD, MBA
Xianbin Yang, PhD, MBA Director AM Biotechnologies How did you become interested in the field of oligonucleotides? I’ve been fascinated with nucleic acid chemistry and biology since my undergraduate study. I received my
Interview with Eli Gilboa, PhD
Eli Gilboa Ph.D. Dodson Professor of Microbiology & Immunology University of Miami Miller School of Medicine How did you become interested in the field of oligonucleotides? A main interest and focus of my lab is cancer immunotherapy. The overall approach has been
Interview with Maureen McKeague, PhD
Maureen McKeague, PhD, Postdoctoral Scholar, Bioengineering Department, Stanford University How did you become interested in the field? I’ve been fascinated with nucleic acids ever since high school biology. In my undergraduate degree, I enjoyed genetics
Interview with Bart Klein
ProQR Therapeutics Property, Head of Intellectual Property How did you become interested in the field? I am a Dutch and European patent attorney with a Masters in Chemical Biology/Molecular Biology from Utrecht University, The Netherlands (Msc. 1988).